StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$13.14−0.15 (-1.13%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

Ascentage Pharma Group International cash

Cash and short-term investments held at the end of each period.

Ascentage Pharma Group International's cash was CN¥1.20B at Dec 31, 2025. For fiscal 2025 it was CN¥1.20B, up 33.9% from the year before. The highest annual figure on record is CN¥1.71B in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥1.20B+33.9%
FY2024Dec 31, 2024CN¥893.10M-14.0%
FY2023Dec 31, 2023CN¥1.04B-22.9%
FY2022Dec 31, 2022CN¥1.35B-21.2%
FY2021Dec 31, 2021CN¥1.71B–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CN¥1.20B-29.9%
Q4 FY2024Dec 31, 2024CN¥893.10M–
Q4 FY2023Dec 31, 2023CN¥1.04B–
Q4 FY2022Dec 31, 2022CN¥1.35B–
Q4 FY2021Dec 31, 2021CN¥1.71B–

More Ascentage Pharma Group International figures

See a number that looks wrong?